| 2-HG | 2-hydroxyglutarate |
| 5-FU | 5-fluorouracil |
| ACC | acetyl CoA carboxylase |
| 2-HG | 2-hydroxyglutarate |
| ADP | adenosine diphosphate |
| αKG | α ketoglutarate |
| AKT | protein kinase B |
| AML | acute myeloid leukemia |
| AMPK | 5’ AMP-activated protein kinase |
| Bax | Bcl-2-associated X protein |
| BW | body weight |
| CAF | cancer-associated fibroblast |
| CD | cluster of differentiation |
| CDK | cyclin-dependent kinase |
| CIMP | CpG island methylator phenotype |
| COX | cyclooxygenase |
| CRC | colorectal cancer |
| CSC | cancer stem cell |
| CYP | cytochrome P450 |
| DCA | dichloroacetate |
| dMMR | DNA mismatch repair system |
| DNA | deoxyribonucleic acid |
| E4BP | eIF4E binding protein |
| ECM | extracellular matrix |
| EGFR | endothelial growth factor receptor |
| EMA | European Medicines Agency |
| EMT | epithelial–mesenchymal transition |
| ERK | extracellular-signal regulated kinases |
| FAD | flavin adenine dinucleotide |
| FDA | Food and Drug Administration |
| FOLFIRI | fluorouracil, leucovorin and irinotecan |
| FOLFIRINOX | fluorouracil, leucovorin, irinotecan and oxaliplatin |
| FOLFOX | fluorouracil, leucovorin and oxaliplatin |
| G6PD | glucose-6-phosphate dehydrogenase |
| GLS | glutaminase |
| GLUD | glutamate dehydrogenase |
| GLUT | glucose transporter |
| GOT | glutamic-oxaloacetic transaminase |
| GTP | glutamate pyruvate transaminase |
| GTP | guanosine-5’-triphosphate |
| HIF | hypoxia-inducible factor |
| HK | hexokinase |
| HRE | hypoxia response element |
| IBD | inflammatory bowel disease |
| IC50 | inhibitory concentration (50%) |
| IDH | isocitrate dehydrogenase |
| IGF | insulin-like growth factor |
| KGDH | α-ketoglutarate dehydrogenase complex |
| LA | α-lipoic acid |
| LC3B | microtubule-associated protein |
| LDHA | lactate dehydrogenase A |
| MAPK | mitogen-activated protein kinase |
| MCT | monocarboxylate transporter |
| MDR | multidrug resistant protein |
| MGMT | O6-methylguanine-DNA methyltransferase |
| MOM | mitochondrial outer membrane |
| MPC | mitochondrial pyruvate carrier |
| MSI | microsatellite instable |
| MSS | microsatellite stable |
| mtDNA | mitochondrial DNA |
| MTD | maximum tolerable dose |
| MTHFD2 | methylenetetrahydrofolate dehydrogenase |
| mTOR | mammalian target of rapamycin |
| MYC | myelocytomatosis |
| NFκB | nuclear factor ‘kappa-light-chain-enhancer’ of activated B-cells |
| Nrf | nuclear factor erythroid-2-related factor |
| OXPHOS | oxidative phosphorylation |
| PARP | poly(ADP-ribose) polymerase |
| PDGF | platelet-derived growth factor |
| PGC | peroxisome proliferator-activated receptor gamma coactivator |
| PDC | pyruvate dehydrogenase complex |
| PDCD4 | programmed cell death protein |
| PDK | pyruvate dehydrogenase kinase |
| PEG2 | prostaglandin E2 |
| PEG | polyethylene glycol |
| PET | positron emission tomography |
| PFK | phosphofructokinase |
| PHD | prolyl hydroxylase domain protein |
| PI3K | phosphoinositide 3-kinases |
| PIP2 | phosphatidylinositol-4,5-bisphosphate |
| PIP3 | phosphatidyl-inositol-3,4,5-trisphosphate |
| PKM | pyruvate kinase |
| PPP | pentose phosphate pathway |
| ROS | reactive oxygen species |
| RTK | receptor tyrosine kinases |
| S6K1 | p70S6 Kinase 1 |
| S9 | supernatant 9000 g,— |
| SCO | synthesis of cytochrome c oxidase |
| SLC | solute carrier |
| SREBP | sterol responsive element binding protein |
| TAM | tumor associated macrophages |
| TCA | tricarboxylic acid cycle |
| Teff cell | effector T cell |
| TGF | transforming growth factor |
| TME | tumor microenvironment |
| TIGAR | TP53-inducible glycolysis and apoptosis regulator |
| Treg cell | regulatory T cell |
| VEGF | vascular endothelial growth factor |